Agilon 001-AGL
Agilon 001-AGL is a synthetic bone graft (FDA Class II; FDA product code MQV, Filler, Bone Void, Calcium Compound) made by Biogennix, LLC, cleared under FDA 510(k) K193168 on 13 Feb 2020 (1 earlier submission) and listed in FDA GUDID since 15 Apr 2022 (UDI-DI 00812593020675), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00812593020675 | Date15 Apr 2022 | StatusListed |
| United States | FDA 510(k)SESE | NumberK193168 | Date13 Feb 2020 | StatusActive |
Official records
- AccessGUDID record 00812593020675
- FDA 510(k) database K193168
- FDA 510(k) database K190371
From the FDA record
- Device description
- Agilon Moldable 1.5cc
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA 510(k) K193168 decided 13 Feb 2020 Active
- FDA GUDID UDI-DI 00812593020675 listed 15 Apr 2022 Listed
Timeline
- Cleared FDA 510(k) K190371
- Cleared FDA 510(k) K193168
- Listed FDA GUDID 00812593020675
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Agilon
- Generic name
- Synthetic bone graft
- Model / Ref / Catalog
- 001-AGL, Agilon
- Primary DI / UDI-DI
- 00812593020675
- FDA product code
- MQV
- GMDN term
- Synthetic bone graft
- Device class
- Class II
- Regulation number
- 888.3045
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Synthetic bone graft.